Ron Ziegler
This article was originally published in The Tan Sheet
Executive Summary
Former National Association of Chain Drug Stores CEO Ronald Ziegler died of a heart attack Feb. 10 at the age of 63. Ziegler served as head of NACDS from January 1988 until February 1999, when he left the association for health reasons (1"The Tan Sheet" Feb. 15, 1999, p. 24). Under his leadership, NACDS quadrupled in size from $7 mil. in revenues and 25 staffers to over $28 mil. in revenues and 95 employees by the end of his tenure. Ziegler, who was living in Coronado, Calif. at the time of his death, is survived by his wife Nancy, his mother and two daughters...
You may also be interested in...
NACDS
Robert Hannan will serve as interim president and CEO following Ronald Ziegler's retirement Feb. 28. Hannan was president and CEO of Thrift Drug for 10 years until the chain was acquired by J.C. Penney and merged with Eckerd in 1997. After serving as Eckerd vice chairman during the transition, Hannan retired in 1998. He was NACDS chairman from 1993 to 1994. Ziegler will retire at the end of February "because of health reasons," NACDS announces Feb. 8. Ziegler previously said he would retire in December 2000 after a successor was named ("The Tan Sheet" Feb. 1, p. 27). However, in a series of meetings with the association board in Miami, "he concluded that it was in his best interest to initiate his retirement sooner than originally planned," NACDS says. The association emphasizes that "Ziegler and the entire board hold one another in the highest regard and in the highest terms of respect"
QUOTED. 25 January. 2021. Scott Whitaker.
US President Joe Biden has invoked the Defense Production Act to ramp up COVID-19 tests and personal protective equipment. See what AdvaMed’s CEO Scott Whitaker wrote in a letter to Biden where he asked that the device industry be included in the administration’s decision-making process.
Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: